The ROE as of September 2024 (TTM) for Sino Biopharmaceutical Limited (SBHMY) is 1.69%

According to Sino Biopharmaceutical Limited’s latest financial reports and current stock price. The company's current ROE is 1.69%. This represents a change of 519.18% compared to the average of 0.27% of the last 4 quarters.

Sino Biopharmaceutical Limited (SBHMY) Historical ROE (quarterly & annually)

How has SBHMY ROE performed in the past?

The mean historical ROE of Sino Biopharmaceutical Limited over the last ten years is 20.92%. The current 1.69% ROE has changed -91.92% with respect to the historical average. Over the past ten years (40 quarters), SBHMY's ROE was at its highest in in the June 2021 quarter at 26.72%. The ROE was at its lowest in in the September 2023 quarter at 0%.

Sino Biopharmaceutical Limited (SBHMY) ROE by Quarter and Year

Discovering the peaks and valleys of Sino Biopharmaceutical Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sino Biopharmaceutical Limited (SBHMY) Average ROE

How has SBHMY ROE performed in the past?

The current ROE of Sino Biopharmaceutical Limited (SBHMY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Sino Biopharmaceutical Limited (SBHMY) ROE vs. Peers

How is SBHMY’s ROE compared to its peers?

Sino Biopharmaceutical Limited’s ROE is less than Institute of Biomedical Research Corp. (131.12%), less than Defence Therapeutics Inc. (1.57%), greater than Aileron Therapeutics, Inc. (-47.94%), greater than Enlivex Therapeutics Ltd. (-71.76%), greater than Protagenic Therapeutics, Inc. (-238.37%), less than ZIVO Bioscience, Inc. (673.84%), greater than Cyteir Therapeutics, Inc. (-23.13%), greater than Eledon Pharmaceuticals, Inc. (-124.74%), less than Opthea Limited (360.05%), greater than Centessa Pharmaceuticals plc (-63.22%), greater than Nuvalent, Inc. (-28.83%), greater than Tarsus Pharmaceuticals, Inc. (-63.99%), greater than Genfit S.A. (-60.96%), greater than Anebulo Pharmaceuticals, Inc. (-122.97%), greater than Tempest Therapeutics, Inc. (-201.10%), greater than RenovoRx, Inc. (-403.38%), greater than Acrivon Therapeutics, Inc. Common Stock (-47.31%), greater than Acurx Pharmaceuticals, Inc. (-371.20%), greater than Fennec Pharmaceuticals Inc. (-52.10%), greater than XOMA Corporation (-19.34%), greater than Kezar Life Sciences, Inc. (-54.50%), greater than Longboard Pharmaceuticals, Inc. (-36.93%), less than Entrada Therapeutics, Inc. (35.16%),

Build a custom stock screener for Sino Biopharmaceutical Limited (SBHMY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sino Biopharmaceutical Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sino Biopharmaceutical Limited (SBHMY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sino Biopharmaceutical Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.